Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Pre-close Trading Statement

25 Jan 2018 07:00

RNS Number : 8506C
Biome Technologies PLC
25 January 2018
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR")

 

 

25 January 2018

Biome Technologies plc

 ("Biome", "the Company" or "the Group")

 

Pre-close Trading Statement

 

 

Biome Technologies plc's pre-close trading statement for the financial year ended 31 December 2017 is set out below.

 

Group revenues for the year were £6.2m, 36% ahead of the 2016 revenues of £4.6m.

 

Revenues in the Bioplastics division were £2.3m, an increase of 44% on 2016 revenues of £1.6m. The Bioplastics division benefitted from an increase in the use of its material for the coffee market following the commercialisation of the innovative BiomeMesh filter material. The shifting perception of plastic waste both in public opinion and amongst policy-makers, particularly in the UK, provides encouragement for future growth in the use of bioplastic products.

 

The RF division also had a strong year with revenues of £4.0m, an increase of 32% over 2016 revenues of £3.0m. The increase in revenues is attributable mainly to robust demand for the fibre optic furnace products underpinned by the roll out of infrastructure investment in telecommunications, including "5G", in Asia. As 2018 commences, the RF division has a strong order book which is ahead of that at the comparable point in 2017.

 

The Group's cash position at 31 December 2017 was £2.3m (30 September 2017: £2.4m; 31 December 2016: £1.5m). The increase in cash year on year is a mixture of trading performance, working capital movements and the £0.45m received under the previously reported settlement agreement.

 

The Board expects that the Group will record a small profit before interest, tax, depreciation, amortisation, and share option charges ("EBITDA") for the 2017 financial year (2016: trading EBITDA loss of £0.2m excluding the settlement agreement).

 

The audited results for the year ended 31 December 2017 are scheduled to be published on 27 March 2018.

 

 

-Ends-

 

 

 

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDZLFLVFFXBBQ
Date   Source Headline
27th Mar 20192:05 pmRNSSecond Price Monitoring Extn
27th Mar 20192:00 pmRNSPrice Monitoring Extension
13th Mar 20191:54 pmRNSHoldings in Company
24th Jan 20197:00 amRNSPre-close Trading Statement
31st Dec 20187:00 amRNSTotal Voting Rights
10th Dec 20182:35 pmRNS2017 Long Term Incentive Plan - First Vesting
6th Dec 20187:00 amRNSGrant funding from Innovate UK
23rd Nov 201812:38 pmRNSBiome to present at Mello London
1st Nov 20187:00 amRNSTrading update
3rd Sep 20187:00 amRNSInterim Results
23rd Jul 20187:00 amRNSTrading Update
31st May 20185:00 pmRNSTotal Voting Rights
2nd May 20184:13 pmRNSIssue of shares to directors & PDMR shareholdings
2nd May 20183:27 pmRNSProposed issue of shares to directors and dealings
24th Apr 201810:40 amRNSResult of Annual General Meeting
24th Apr 20187:00 amRNSTrading update
28th Mar 20181:52 pmRNSNotice of AGM and Annual Report and Accounts
27th Mar 20187:00 amRNSPreliminary Results
19th Feb 20182:05 pmRNSSecond Price Monitoring Extn
19th Feb 20182:00 pmRNSPrice Monitoring Extension
25th Jan 20187:00 amRNSPre-close Trading Statement
21st Dec 20177:00 amRNSNew LTIP and option grant
1st Nov 20177:00 amRNSTrading Update
4th Sep 20177:00 amRNSHalf-year Report
26th Jul 20179:30 amRNSDirector/PDMR Shareholding
25th Jul 20174:50 pmRNSDirector/PDMR Shareholding
24th Jul 20177:00 amRNSTrading Update
24th Apr 201710:45 amRNSResult of AGM
24th Apr 20177:00 amRNSTrading Update
31st Mar 20172:50 pmRNSNotice of AGM and Annual Report and Accounts
29th Mar 20177:00 amRNSPreliminary Results
20th Jan 20177:00 amRNSPre-close Trading Statement
18th Jan 20177:00 amRNSSettlement Agreement
2nd Nov 20167:00 amRNSTrading Update
31st Aug 20167:00 amRNSHalf-year Report
27th Jun 20167:00 amRNSTrading Update
25th Apr 201612:34 pmRNSResult of Annual General Meeting
25th Apr 20167:00 amRNSTrading Update
1st Apr 201610:42 amRNSNotice of AGM and Annual Report and Accounts
30th Mar 20167:00 amRNSFinal Results
26th Jan 20167:00 amRNSPre-close Trading Statement
3rd Nov 20157:00 amRNSTrading Statement
2nd Sep 20157:00 amRNSInterim Results
23rd Jul 20157:00 amRNSTrading Update
19th Jun 20159:00 amRNSNew Contract
27th Apr 20154:46 pmRNSResult of AGM
27th Apr 20157:00 amRNSTrading Update
27th Mar 20153:43 pmRNSNotice of Annual General Meeting
25th Mar 20157:00 amRNSPreliminary Results
19th Feb 20153:26 pmRNSFunding Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.